IXICO wins contract in new therapeutic area with largest pharma client
IXICO PLC (LON:IXI, OTCMKTS:PHYOF) has won a contract with its largest pharma client, providing its neuroimaging services for a new clinical trial for acute ischemic stroke.
Ischemic stroke is caused by a blockage cutting off the blood supply to the brain and is the most common form of stroke.
The new Phase II acute ischemic stroke trial will be conducted across 50 sites in North America and Europe and is worth in excess of US$0.5mln over 35 months.
While also building momentum in its growth strategy of further diversification into new therapeutic areas, the artificial intelligence (AI) data analytics company said the contract win reflects a broadening of its neurological footprint into a new therapeutic area with this client.
“We are delighted to be awarded this new study by our existing pharma client,” said Lammert Albers, the AIM-listed company’s chief commercial officer.
“Having singularly focused on neurological disorders since our inception in 2004, IXICO has a long and established history of delivering advanced neuroimaging solutions to the biopharmaceutical sponsors. This new contract demonstrates our continually expanding footprint and deepening expertise within IXICO’s proven specialist domain.”
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/947880/ixico-wins-contract-in-new-therapeutic-area-with-largest-pharma-client-947880.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Visits: | 1,706,517,730 |
| Stories: | 8,445,879 |
Whistler Blowers, Insiders
